Premium
Late reactivation of resolved hepatitis B virus infection: An increasing complication post rituximab‐based regimens treatment?
Author(s) -
GarciaRodriguez Maria J.,
Canales Miguel A.,
HernandezMaraver Dolores,
HernandezNavarro Fernando
Publication year - 2008
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.21214
Subject(s) - medicine , rituximab , hepatitis b virus , complication , hbsag , lymphoma , hepatitis b , immunology , virology , virus , gastroenterology
Reactivation of hepatitis B infection is an increasing problem for patients with lymphoma, even in resolved infections, who were treated with rituximab‐based regimens. Our cases point out the need of prolonged prophylaxis in HBsAg‐negative patients due to the high risk of developing fatal reactivation. Am. J. Hematol., 2008. © 2008 Wiley‐Liss, Inc.